Rapid Bio recently welcomed a high‑level delegation from the Department of Health — Abu Dhabi (DoH‑AD) to explore how state‑of‑the‑art Russian test systems could reshape healthcare across the Middle East and North Africa.
During the visit, Rapid Bio’s leadership held in‑depth talks with:
The guests toured Rapid Bio’s production lines, gaining a behind‑the‑scenes look at the rigorous R&D and manufacturing processes that underpin the company’s rapid diagnostic kits.
Conversations focused on a shared vision: deploying reliable, affordable, and scalable test systems that could bolster preventive medicine and outbreak preparedness throughout the region. Both sides outlined concrete steps for regulatory alignment, technology transfer, and workforce training—laying the groundwork for a partnership that could set new benchmarks for MENA healthcare.
During the visit, Rapid Bio’s leadership held in‑depth talks with:
- Dr Noura Al Ghaithi — Deputy Undersecretary, DoH‑AD
- H.E. Khalaf Al Mazrouei — Director General for Corporate Support & Public Affairs
- Dr Asma Al Mannaei — Executive Director, Life Sciences Sector
- Dr Faiza Al Yafei — Executive Director, Healthcare Quality
- Dr Faisal Al Ahbabi — Acting Executive Director, Communicable Diseases, Abu Dhabi Public Health Center
The guests toured Rapid Bio’s production lines, gaining a behind‑the‑scenes look at the rigorous R&D and manufacturing processes that underpin the company’s rapid diagnostic kits.
Conversations focused on a shared vision: deploying reliable, affordable, and scalable test systems that could bolster preventive medicine and outbreak preparedness throughout the region. Both sides outlined concrete steps for regulatory alignment, technology transfer, and workforce training—laying the groundwork for a partnership that could set new benchmarks for MENA healthcare.